ALNTAllient Inc.
Allient Inc. (ALNT) sells medical equipment and supplies, primarily targeting hospitals and healthcare providers. The next catalyst is Nov 4, 2026 — Q3 2026 Earnings Release, which will test the company’s ability to sustain recent revenue growth and margin expansion. The stock historically reacts to partnerships and similar catalysts with a median absolute move of about 17% .
- Revenue grew 4.6% YoY to $571.01M, with net income of $27.58M and diluted EPS of $0.61.
- Free cash flow (TTM) reached $90.33M, with a net margin of 4.8% and a debt-to-equity ratio of 0.23x.
- Shareholders’ equity stands at $301.45M, reflecting a solid capital structure.
The Read
Allient's stock historically reacts to partnerships and similar catalysts with a median absolute move of about 17%.
The schedule
- Wed4Nov
The earnings release tests whether the company can deliver consistent revenue and margin expansion, following a recent bearish print that missed guidance. This event is more about the forward guidance and mix than the headline.
- Wed20Jan
This update tests the company's ability to align with broader industrial and power equipment cycles, which have been volatile. The last similar event saw a bearish outcome due to weak demand signals.
- Tue9Feb
The Q4 earnings release will test the company's ability to meet or exceed guidance, with a focus on cash flow and margin performance. The last similar event saw a strong bull move due to improved margin expansion.
- Wed5May
The Q1 earnings release will test the company's ability to sustain momentum from the previous quarter, with a focus on revenue growth and operational efficiency. The last similar event saw a mixed outcome due to supply chain disruptions.
- Wed4Aug
The Q2 earnings release will test the company's ability to maintain growth and margin expansion, with a focus on long-term strategic initiatives. The last similar event saw a strong bull move due to successful cost optimization.
Past
- Fri18Sep
Actual outcome: Bull · $116.07 at outcome
ALNT's stock surged 15.4% following the debt refinancing and capital allocation update, surpassing the bull target of $85.00. The announcement included a strategic shift toward growth initiatives and a revised dividend strategy, which signaled confidence in the company's financial flexibility and long-term value creation. These developments aligned with the bull case, driving the rally despite a mixed earnings report.
With elevated debt on the balance sheet, an update on refinancing strategies and potential expansions to the 33% dividend hike announced in Q1 will be evaluated by investors from a $78.00 base.
- Wed5Aug
Actual outcome: Bull · $114.28 at outcome
Allient reported Q2 earnings of $0.32 per share, matching the estimate, and delivered double-digit revenue growth, a record gross margin, and strong orders. The positive guidance and strategic developments reinforced investor confidence, driving the stock above the bull target.
Allient reports Q2 earnings as the market scrutinizes top-line growth and margin preservation following its Q1 revenue and EPS misses. Starting at an assumed $89.50 level, the print carries substantial downside risk if execution falters.
- Wed1Jul
Actual outcome: Bear · $84.24 at outcome
Allient shares remained flat through the Federal Defense Contract Awards Cycle as anticipated government procurement wins were already fully priced into the stock's 69x P/E multiple. Without unexpected contract volumes or major surprise announcements to justify further multiple expansion, the defense hardware backlog additions merely met high market expectations, resulting in a muted price reaction.
The government procurement window opens under President Trump, and Allient is positioned to secure backlog in defense hardware. However, at a $97.97 base price, shares trade at nearly 69x P/E, implying substantial contract wins are fully priced in.
- Sat20Jun
Actual outcome: Bull · $100.92 at outcome
ALNT successfully navigated the tariff and trade policy shock, with its stock maintaining levels well above the $89.00 bull target despite a negligible fractional dip during the week. The market rewarded the company's resilient supply chain positioning, signaling confidence that ALNT can manage potential industrial component disruptions and tariff implementations without material margin degradation.
Market pricing of potential supply chain disruptions and tariff implementations affecting industrial components.
- Wed6May
Actual outcome: Bear · $62.10 at outcome
Allient missed both earnings and revenue estimates for the first quarter, reporting earnings of $0.50 per share against a consensus of $0.55. Despite the company highlighting revenue growth, margin expansion, strong bookings, and a 33% dividend increase, the top- and bottom-line misses disappointed investors, driving a nearly 20% sell-off that pushed the stock well below its bear floor.
Q1 2026 earnings on 2026-05-06 will test whether Allient can sustain double-digit revenue and margin expansion after its recent rally from industrial CAPEX strength, with the stock likely oscillating between a bullish scenario near $79.0 and a downside reset toward $79.00 versus the current $74.12.
- Wed15Apr
Actual outcome: Bull · $73.92 at outcome
The anticipated industrial CAPEX slowdown failed to materialize as power equipment stocks surged to new highs, outperforming 96% of the market and signaling robust demand across the sector. This strong industry momentum drove Allient's price well past the $63.50 bull target to $71.81 by the run date, as investors favored the sector's breakout performance over macro concerns. Despite minor institutional selling from JPMorgan, the fundamental strength in power equipment demand provided a clear catalyst for the rally.
Assessment of order trends and customer CAPEX behavior across industrial, aerospace, and medical end-markets around mid-April, as channel checks and macro data either confirm or refute a slowdown narrative for Allient at $60.23.
- Thu5Mar
Actual outcome: Mixed · $60.95 at outcome
Allient delivered strong Q4 2025 results, highlighting revenue growth, margin expansion, and meaningful deleveraging, alongside an earnings beat reported at $0.55 per share. Despite these positive fundamental developments and a surge in trading volume, the stock's price reaction was muted, falling just 1.8% by the outcome date. The lack of a significant directional move following the earnings release resulted in a mixed outcome.
Release of Q4 2025 results and critical 2026 guidance. Given the P/E of 54.75 and the analyst consensus target of $35.00, the stock is pricing in perfection. Any disappointment or conservative guidance due to macro/industrial softness will lead to a sharp valuation reset.
